Literature DB >> 21719581

Fidaxomicin approved for C. difficile infections.

Kate Traynor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21719581     DOI： 10.2146/news110046

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  Fidaxomicin (Dificid), a Novel Oral Macrocyclic Antibacterial Agent For the Treatment of Clostridium difficile-Associated Diarrhea in Adults.

Authors:  Martin Paspe Cruz
Journal:  P T       Date:  2012-05

2.  Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea.

Authors:  Yoav Golan; Lauren Epstein
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 3.  New target for inhibition of bacterial RNA polymerase: 'switch region'.

Authors:  Aashish Srivastava; Meliza Talaue; Shuang Liu; David Degen; Richard Y Ebright; Elena Sineva; Anirban Chakraborty; Sergey Y Druzhinin; Sujoy Chatterjee; Jayanta Mukhopadhyay; Yon W Ebright; Alex Zozula; Juan Shen; Sonali Sengupta; Rui Rong Niedfeldt; Cai Xin; Takushi Kaneko; Herbert Irschik; Rolf Jansen; Stefano Donadio; Nancy Connell; Richard H Ebright
Journal:  Curr Opin Microbiol       Date:  2011-08-19       Impact factor: 7.934
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.